Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Hypoesthesia, Slowness of movement (bradykinesia), Cerebellar dentate nucleus calcification, and Brain atrophy and others; and common findings: Slurred speech, Ataxia, and Thalamic calcification. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Slowness of movement (bradykinesia), Dystonia, Slurred speech |
MYORG encodes myogenesis regulating glycosidase (714 aa). Alpha-galactosidase with unusual specificity for the Gal-alpha1,4-Glc structure, whose in vivo substrate is still unknown. Highest expression in Muscle Skeletal (35.2 TPM) and Brain Caudate basal ganglia (31.2 TPM).
Basal ganglia calcification, idiopathic, 7, autosomal recessive is associated with mutations in the MYORG gene on chromosome 9.
MYORG is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for MYORG is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for basal ganglia calcification, idiopathic, 7, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 3 common features.
No clinical trials have been registered for basal ganglia calcification, idiopathic, 7, autosomal recessive.
5 publications have been identified in PubMed for basal ganglia calcification, idiopathic, 7, autosomal recessive. Research spans Basic Science / Preclinical (40%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Yektay Farahmand M (2025). [PMID: 40947452](https://pubmed.ncbi.nlm.nih.gov/40947452/). *Journal of neurology*. [Basic Science / Preclinical]
Emmi A (2025). [PMID: 39935191](https://pubmed.ncbi.nlm.nih.gov/39935191/). *Annals of clinical and translational neurology*. [Diagnostic / Biomarker]
Yang D (2025). [PMID: 40456615](https://pubmed.ncbi.nlm.nih.gov/40456615/). *eNeuro*. [Review / Meta-Analysis]
Bonato G (2024). [PMID: 38999439](https://pubmed.ncbi.nlm.nih.gov/38999439/). *Journal of clinical medicine*. [Basic Science / Preclinical]
Cao C (2024). [PMID: 38859923](https://pubmed.ncbi.nlm.nih.gov/38859923/). *Frontiers in neuroscience*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:30 PM UTC
Online Mendelian Inheritance in Man
Common questions about basal ganglia calcification, idiopathic, 7, autosomal recessive
Muscles |
2 |
Brain atrophy, Reduced tendon reflexes |
Eyes | 1 | Hypometric saccades |
Digestive system | 1 | Difficulty swallowing (dysphagia) |